Published in

Elsevier, Journal of Hepatology, 1(67), p. 1-4, 2017

DOI: 10.1016/j.jhep.2017.04.007

Elsevier, Journal of Hepatology, 4(66), p. 671-674, 2017

DOI: 10.1016/j.jhep.2017.01.015

Elsevier, Journal of Hepatology, 3(66), p. 469-472, 2017

DOI: 10.1016/j.jhep.2016.12.021

Links

Tools

Export citation

Search in Google Scholar

From the Editor’s desk…

Journal article published in 2015 by Richard Moreau ORCID, Ramon Bataller, Thomas Berg, Jessica Zucman-Rossi ORCID, Rajiv Jalan
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

The most efficient strategy to treat chronic liver disease including NAFLD is to remove the cause (i.e., hypocaloric diet and aerobic exercise in patients with NAFLD). Although aerobic exercise reduces liver fat and visceral adipose tissue, there are limited prospective studies assessing the effect of different exercise programs. The study from Keating et al. investigated the effects of different programs of aerobic exercise (low to moderate intensity, high volume vs. high intensity, low volume aerobic). The authors found that both aerobic exercise regimens reduced liver and visceral fat and VAT without significant weight loss. This important study supports that exercise should be advised, when possible, to patients with NAFLD. For patients unable to modify their lifestyle, targeted therapies are needed.